On April 13, Mizuho lowered its price recommendation on Embecta Corp. (NASDAQ:EMBC) to $12 from $14. It reiterated a Neutral ...

Embecta’s implied fair value has been reset from US$16.67 to US$15.00, giving you a fresh reference point for where analysts now see the stock. That reduction lines up with recent commentary that ...

Shares of Embecta (NASDAQ: EMBC.V) were tanking on Friday, falling 13% lower as of 10:54 a.m. ET. The decline came after the diabetes care company reported its fiscal year 2024 first-quarter results.

Becton, Dickinson and Co.’s board of directors approved the company’s diabetes spinoff, and set a date of April 1 for the move. The announcement of Embecta Corp.’s approval came Feb. 1, along with a ...

The January ribbon cutting at embecta‘s new global headquarters in Parsippany was the latest step for one of the world’s largest pure-play diabetes management companies. “It was a really important ...

When Embecta spun out from BD just over a year ago, the newly formed diabetes giant already carried breakthrough designation for an insulin patch pump that would specifically target the Type 2 ...

It can be difficult for a spinout to distinguish itself from its parent company—especially if that company has been around for a century. Just ask Embecta CEO Devdatt Kurdikar, Ph.D., who discussed ...

Shares are trading at a reported 4.1x forward earnings, offer a 5.2% dividend yield, and the stock is down more than 40% YTD, thus representing a fat discount to recent prices. Seems like a bargain at ...

Embecta releases earnings for the most recent quarter on November 21. Wall Street analysts expect Embecta will report earnings per share of $0.398. Watch Embecta stock price in real-time on Markets ...

Embecta said on May 12, 2023 that its board of directors declared a regular quarterly dividend of $0.15 per share ($0.60 annualized). Previously, the company paid $0.15 per share. Shares must be ...

Under the transaction terms, BD shareholders received one share of Embecta stock for every five shares of BD that they held as of March 22. The Embecta spinoff severs all financial ties to BD, which ...

The company reported its results for the first quarter of fiscal 2023. It scored convincing beats on both the top and bottom lines. Before market open, Embecta published the figures for its first ...